Search Results - N. Yu. Samaneva

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Blood levels of growth and progression factors in patients with locally advanced breast cancer during neoadjuvant chemotherapy

    Blood levels of growth and progression factors in patients with locally advanced breast cancer during neoadjuvant chemotherapy by E. M. Frantsiyants, N. Yu. Samaneva, L. Yu. Vladimirova, A. E. Storozhakova, E. A. Kalabanova, S. N. Kabanov, A. V. Tishina

    Published 2021-09-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Diagnosis of acute myelomonocytic leukemia in a patient with extramedullary testicular lesion

    Diagnosis of acute myelomonocytic leukemia in a patient with extramedullary testicular lesion by N. K. Guskova, O. N. Selyutina, I. B. Lysenko, E. A. Guskova, A. K. Donskaya, N. Yu. Samaneva, E. A. Kapuza, T. F. Pushkareva

    Published 2022-11-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Experience of pemetrexed in maintenance therapy for metastatic lung adenocarcinoma

    Experience of pemetrexed in maintenance therapy for metastatic lung adenocarcinoma by L. Yu. Vladimirova, A. E. Storozhakova, E. A. Kalabanova, P. N. Meshcheryakov, S. V. Oskin, S. N. Kabanov, N. Yu. Samaneva, Ya. V. Svetitskaya, A. V. Tishina

    Published 2021-03-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    HORMONE-POSITIVE HER2-NEGATIVE METASTATIC BREAST CANCER: DECISION MAKING IN REAL CLINICAL PRACTICE

    HORMONE-POSITIVE HER2-NEGATIVE METASTATIC BREAST CANCER: DECISION MAKING IN REAL CLINICAL PRACTICE by L. Yu. Vladimirova, A. E. Storozhakova, T. A. Snezhko, L. K. Strakhova, N. A. Abramova, S. N. Kabanov, E. A. Kalabanova, N. Yu. Samaneva, Ya. V. Svetitskaya, A. V. Tishina

    Published 2020-06-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Expression of LAG-3 on B-lymphocytes as a marker for prediction of response to therapy in patients with chronic lymphocytic leukemia

    Expression of LAG-3 on B-lymphocytes as a marker for prediction of response to therapy in patients with chronic lymphocytic leukemia by O. N. Selyutina, I. B. Lysenko, N. K. Guskova, I. A. Novikova, E. Yu. Zlatnik, T. F. Pushkareva, N. V. Nikolaeva, I. A. Kamaeva, N. Yu. Samaneva, E. A. Kapuza

    Published 2023-05-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    Bevacizumab in maintenance therapy for ovarian cancer patients

    Bevacizumab in maintenance therapy for ovarian cancer patients by L. Yu. Vladimirova, A. E. Storozhakova, E. A. Kalabanova, E. V. Verenikina, S. N. Kabanov, Ya. V. Svetitskaya, N. Yu. Samaneva, N. M. Tikhanovskaya, K. A. Novoselova, O. G. Selezneva, A. V. Tishina

    Published 2020-08-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    EXPERIENCE OF USING PERTUZUMAB IN ANTICANCER THERAPY FOR HER2-POSITIVE BREAST CANCER

    EXPERIENCE OF USING PERTUZUMAB IN ANTICANCER THERAPY FOR HER2-POSITIVE BREAST CANCER by O. I. Kit, L. Yu. Vladimirova, E. A. Kalabanova, A. E. Storozhakova, S. N. Kabanov, T. A. Snezhko, I. S. Mitashok, Ya. V. Svetitskaya, N. Yu. Samaneva, I. S. Kornilova, Yu. V. Przhedetskiy, V. V. Pozdnyakova, N. A. Abramova, I. L. Popova, N. M. Tikhanovskaya, A. A. Lyanova, K. A. Novoselova, L. A. Ryadinskaya

    Published 2021-05-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: